Showing 1–5 of 5 results
-
-
Correspondence |
-
Research | | Open
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
- Victoria E. R. Parker
- , Kim M. Keppler-Noreuil
- , Laurence Faivre
- , Maxime Luu
- , Neal L. Oden
- , Leena De Silva
- , Julie C. Sapp
- , Katrina Andrews
- , Marc Bardou
- , Kong Y. Chen
- , Thomas N. Darling
- , Elodie Gautier
- , Barry R. Goldspiel
- , Smail Hadj-Rabia
- , Julie Harris
- , Georgios Kounidas
- , Parag Kumar
- , Marjorie J. Lindhurst
- , Romaric Loffroy
- , Ludovic Martin
- , Alice Phan
- , Kristina I. Rother
- , Brigitte C. Widemann
- , Pamela L. Wolters
- , Christine Coubes
- , Lucile Pinson
- , Marjolaine Willems
- , Catherine Vincent-Delorme
- , Pierre Vabres
- , Robert K. Semple
- & Leslie G. Biesecker
-
Research | | Open
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
- Inma M. Berenjeno
- , Roberto Piñeiro
- , Sandra D. Castillo
- , Wayne Pearce
- , Nicholas McGranahan
- , Sally M. Dewhurst
- , Valerie Meniel
- , Nicolai J. Birkbak
- , Evelyn Lau
- , Laurent Sansregret
- , Daniele Morelli
- , Nnennaya Kanu
- , Shankar Srinivas
- , Mariona Graupera
- , Victoria E. R. Parker
- , Karen G. Montgomery
- , Larissa S. Moniz
- , Cheryl L. Scudamore
- , Wayne A. Phillips
- , Robert K. Semple
- , Alan Clarke
- , Charles Swanton
- & Bart Vanhaesebroeck
-
Research |
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
- Marjorie J Lindhurst
- , Victoria E R Parker
- , Felicity Payne
- , Julie C Sapp
- , Simon Rudge
- , Julie Harris
- , Alison M Witkowski
- , Qifeng Zhang
- , Matthijs P Groeneveld
- , Carol E Scott
- , Allan Daly
- , Susan M Huson
- , Laura L Tosi
- , Michael L Cunningham
- , Thomas N Darling
- , Joseph Geer
- , Zoran Gucev
- , V Reid Sutton
- , Christos Tziotzios
- , Adrian K Dixon
- , Timothy Helliwell
- , Stephen O'Rahilly
- , David B Savage
- , Michael J O Wakelam
- , Inês Barroso
- , Leslie G Biesecker
- & Robert K Semple
